lobbying_activities: 2347362

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2347362	5f88b167-bd2d-42fc-a740-75e305d1ef43	Q3	HOLLAND & KNIGHT LLP	18466	TEVA PHARMACEUTICALS USA, INC.	2019	third_quarter	PHA	Drug pricing; Intellectual property; S.1895, Lower Health Care Costs Act; S.1416, Affordable Prescriptions for Patients Act of 2019.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2019-10-17T14:51:43.733000-04:00